Swiss employees call on Merck KGaA to be more like Novartis
This article was originally published in Scrip
The employees at Merck Serono's Geneva headquarters are calling on the management of their German parent company, Merck KGaA, to behave more like their Swiss neighbour Novartis when it comes to restructuring. On the eve of the release of Merck KGaA's first-quarter results and capital markets day, Geneva-based employees were preparing to vote on whether to hold a strike as the company revealed its figures to investors.
You may also be interested in...
GlamorousAI is developing technology to uncover new targets and take on previously intractable disease challenges. Founder Noor Shaker hopes to license a drug to big pharma within the next three years.
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.